BVF Partners LP has recently announced that it has increased stake in Kura Oncology Inc. (NASDAQ:KURA) by 77.09%. After grabbing 6.73 million shares, the institutional investor is now in possession of 2.93 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 9.84% having worth around $65.56 million. Moreover, Suvretta Capital Management LLC increased its share by 0.2 million to have a control over 6.57 million shares. And BlackRock Fund Advisors raised its holdings to 24914.0 shares by acquiring 4.59 million shares or 6.70% of the stake.
Kura Oncology Inc. (KURA) concluded trading on 05/25/23 at a closing price of $13.85, with 1.07 million shares of worth about $14.75 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -9.71% during that period and on Thursday the price saw a loss of about -1.00%. Currently the company’s common shares owned by public are about 68.40M shares, out of which, 64.56M shares are available for trading.
25-cent Stock Takes $11T Commodities Sector Digital
One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.
All the details are in the FREE online report you can get here.
A deeper look into what the analysts at Wall Street are thinking about the price target of this stock provides us with the following: 12 analysts are covering the KURA stock and their offered price forecasts bring an average price target of $31.64. Over the next 12 months, analysts forecasted that the stock’s price could jump as high as $47.00 and could fall to a lowest price of $22.00. The stock’s current price level is 56.23% above of average price target set by the analysts, while a rise to estimated low would result in gain of 37.05% for the stock. However, touching the estimated high of $47.00 would mean a gain of 70.53% for the stock.
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 17 times over the past 12 months. They bought 1,182,493 shares in 5 of the transactions. In 12 selling transactions, insiders dumped 1,640,208 shares.
SPDR S&P Biotech ETF, Vanguard Total Stock Market ETF, and iShares Russell 2000 ETF are the top 3 mutual funds which are holding stakes in Kura Oncology Inc. SPDR S&P Biotech ETF is currently holding 2.37 million shares of worth totaling $23.04 million. The company recently came buying 41415.0 shares which brought its stake up to 3.46% of the company’s outstanding shares. iShares Russell 2000 ETF, after selling 1.36 million shares, have now control over 1.99% of the stake in the company. It holds 19920.0 shares of worth $13.27 million.
Kura Oncology Inc. (NASDAQ: KURA) started trading at $13.90, below -$0.09 from concluding price of the previous day. However, the stock later moved at a day high price of 14.02, or with a loss of -1.00%. Stock saw a price change of 12.42% in past 5 days and over the past one month there was a price change of 36.72%. Year-to-date (YTD), KURA shares are showing a performance of 11.60% which increased to 14.27% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $9.49 but also hit the highest price of $19.93 during that period. The average intraday trading volume for Kura Oncology Inc. shares is 605.51K. The stock is currently trading 17.36% above its 20-day simple moving average (SMA20), while that difference is up 17.74% for SMA50 and it goes to 3.80% higher than SMA200.
BVF Partners LP acquired 6.73 million shares of Kura Oncology Inc. having value of about $65.56 million. Data submitted at the U.S SEC by BVF Partners LP revealed that the firm now holds 2.93 million shares in the company valued at close to $40580500.0, or have control over 77.09% stake in the company. Kura Oncology Inc. (NASDAQ: KURA) currently have 68.40M outstanding shares and institutions hold larger chunk of about 106.44% of that. Holding of mutual funds in the company is about 31.71% while other institutional holders and individual stake holders have control over 69.40% and 11.78% of the stake respectively.
The stock has a current market capitalization of $908.84M and its 3Y-monthly beta is at 0.84. It has posted earnings per share of -$2.04 in the same period. It has Quick Ratio of 21.70 while making debt-to-equity ratio of 0.02. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for KURA, volatility over the week remained 5.91% while standing at 6.34% over the month.
Analysts are in expectations that Kura Oncology Inc. (KURA) stock would likely to be making an EPS of -$0.56 in the current quarter, while forecast for next quarter EPS is -$0.61 and it is -$2.28 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.71 which is -$0.51 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$0.52 in the same quarter a year ago. Stock’s fiscal year EPS is expected to drop by -3.10% while it is estimated to increase by 1.30% in next year. EPS is likely to grow at an annualized rate of 19.93% for next 5-years, compared to annual growth of -5.90% made by the stock over the past 5-years.
Analysts at 12 brokerage firms have issued recommendations for the Kura Oncology Inc. (KURA)’s stock and average of those rates the stock at a “Strong Buy” and assign it a score of 1.60. Out of those 12 Wall Street analysts, 11 recommended a “Buy” rating, while 0 were in favor recommending the stock as a “Hold” and 0 analyst recommended the stock as “Sell”.
Leave a Reply